Stem Cell Therapy for Hemorrhagic Stroke: A Single Case Study Report

Authors

  • Chaitanya Purandare
  • Vaijayantee Belle
  • D. G. Shitole
  • Meghnad Joshi

DOI:

https://doi.org/10.37591/rrjon.v2i2.943

Abstract

Stroke is the leading cause of morbidity and mortality worldwide. Stem cell therapy holds a great promise where transplanted cells can migrate at the site of injury and trigger regeneration of neurons that can lead to functional improvement. The present study was carried out to evaluate the effect of autologous bone marrow and allogeneic cord blood stem cell transplantation in hemorrhagic stroke patients. In the present case report, autologous bone marrow stem cells (BMSCs) and allogeneic cord blood stem cell (CBSCs) transplantation was done intrathecally (L4-L5) in a 54 year old patient who suffered from hemorrhagic stroke. Total five infusions were given. Changes in neurological deficits and functional improvements were compared between pre and post therapy assessments using National Institute Health (NIH) stroke scale. Two year follow up study revealed significant motor, sensory, cognitive, speech and facial improvements. NIH motor score changed from 4 to 1, sensory score from 2 to 0, facial score from 3 to 0 and speech score from 2 to 0 showing significant improvements. In patients with severe cerebral infarcts, the intrathecal infusion of BMSCs and CBSCs appears to be safe therapy without adverse effects, which improves motor, speech, sensory and facial functions.

 

Keywords:  autologous bone marrow stem cells, cord blood stem cells, intrathecal trasplantation, stroke 

Downloads

Published

2019-03-25

Issue

Vol. 2 No. 2 (2012)

Section

Case Study

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.